Eric Bondarsky is a Respiratory physician affiliated with New York University. OpenAlex indexes 40 publications with 221 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year20251 payment
- United Therapeutics CorporationProgram year20254 payments
- Actelion Pharmaceuticals US, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
55.2%Factor Xa inhibitor55.2%Eliquis83%Xarelto17%Part D<11 patientsRespiratory
44.8%beta2-Adrenergic Agonist19.1%Albuterol Sulfate Hfa100%Part D≥22 patientsCorticosteroid14.2%Arnuity Ellipta69%Breo Ellipta31%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Should Your PE Happen During Business Hours: Pert Usage and Temporal Variations
American Journal of Respiratory and Critical Care Medicine
2025 - Long-term impact of add-on sequential triple combination therapy in pulmonary arterial hypertension: real world experience
Therapeutic Advances in Respiratory Disease
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Kenneth Alper, MD
New York University
William Rom, MD
New York University
Alec Megibow, MD
New York University
Edwin Kolodny, MD
New York University
Fernando Martinez, MD
University of Massachusetts Chan Medical School
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”